Century Therapeutics, Inc.IPSCNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+21.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+21.7%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.39M-59.6%
2024$13.36M+13.7%
2023$11.75M+293.1%
2022$2.99M+433.0%
2021$-898000.00+79.6%
2020$-4.40M+98.0%
2019$-224.74M-